The use of rituximab and bendamustine in treating chronic lymphocytic leukaemia (CLL) in end-stage renal disease (ESRD)
Document Type
Journal Article
Publication Date
5-2-2013
Journal
BMJ Case Reports
APA Citation
Shoji, J., & Lew, S. (2013). The use of rituximab and bendamustine in treating chronic lymphocytic leukaemia (CLL) in end-stage renal disease (ESRD). BMJ Case Reports.
Peer Reviewed
1
COinS